Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
Yamamoto T, Hirosue A, Nakamoto M, Yoshida R, Sakata J, Matsuoka Y, Kawahara K, Nagao Y, Nagata M, Takahashi N, Hiraki A, Shinohara M, Nakao M, Saitoh N, Nakayama H. Yamamoto T, et al. Among authors: kawahara k. Br J Cancer. 2020 Aug;123(4):580-590. doi: 10.1038/s41416-020-0907-6. Epub 2020 Jun 5. Br J Cancer. 2020. PMID: 32499570 Free PMC article.
Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR-503-3p-BAK axis.
Yamana K, Inoue J, Yoshida R, Sakata J, Nakashima H, Arita H, Kawaguchi S, Gohara S, Nagao Y, Takeshita H, Maeshiro M, Liu R, Matsuoka Y, Hirayama M, Kawahara K, Nagata M, Hirosue A, Toya R, Murakami R, Kuwahara Y, Fukumoto M, Nakayama H. Yamana K, et al. Among authors: kawahara k. J Extracell Vesicles. 2021 Dec;10(14):e12169. doi: 10.1002/jev2.12169. J Extracell Vesicles. 2021. PMID: 34894384 Free PMC article.
The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation.
Matsuoka Y, Yoshida R, Kawahara K, Sakata J, Arita H, Nkashima H, Takahashi N, Hirayama M, Nagata M, Hirosue A, Kuwahara Y, Fukumoto M, Toya R, Murakami R, Nakayama H. Matsuoka Y, et al. Among authors: kawahara k. Lab Invest. 2022 Aug;102(8):896-907. doi: 10.1038/s41374-022-00776-w. Epub 2022 Apr 12. Lab Invest. 2022. PMID: 35414650 Free PMC article.
Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.
Tanaka T, Nakayama H, Yoshitake Y, Irie A, Nagata M, Kawahara K, Takamune Y, Yoshida R, Nakagawa Y, Ogi H, Shinriki S, Ota K, Hiraki A, Ikebe T, Nishimura Y, Shinohara M. Tanaka T, et al. Among authors: kawahara k. Cancer Sci. 2012 Mar;103(3):455-63. doi: 10.1111/j.1349-7006.2011.02174.x. Epub 2012 Jan 16. Cancer Sci. 2012. PMID: 22136381 Free PMC article.
Osteopontin-integrin α(v)β(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma.
Nakamura T, Shinriki S, Jono H, Ueda M, Nagata M, Guo J, Hayashi M, Yoshida R, Ota T, Ota K, Kawahara K, Nakagawa Y, Yamashita S, Nakayama H, Hiraki A, Shinohara M, Ando Y. Nakamura T, et al. Among authors: kawahara k. FEBS Lett. 2015 Jan 16;589(2):231-9. doi: 10.1016/j.febslet.2014.12.004. Epub 2014 Dec 10. FEBS Lett. 2015. PMID: 25497015 Free article.
1,366 results